Danish pharma major Novo Nordisk and privately-held Californian firm Deep Apple Therapeutics have announced a research ...

South Korean biotech AriBio Co, specializing in neurodegenerative diseases, and a Swiss pharmaceutical company Acino, part of ...

Insmed earlier announced positive top-line results from its randomized, double-blind, placebo-controlled Phase IIb study of ...

The UK’s medicines regulator has released a suite of new guidelines to steer companies through its upcoming decentralized ...

US clinical-stage biotech Oncolytics Biotech today announced the appointment of Jared Kelly as chief executive (CEO) and a ...

Angelini Ventures has joined a syndicate of European life sciences investors to back Elkedonia, a French biotech developing a ...

The UK government has doubled the rate that pharma companies must repay on the sales of newer products to the National Health ...

Germany-based Arvato and Dutch immunology specialist argenx (Euronext: ARGX) have successfully achieved two important ...

China-based biotech Innogen is making a strategic pivot toward international visibility following regulatory clearance of its ...

Italian family-owned drugmaker Chiesi Group and Sweden’s Key2Brain today announced a worldwide license agreement to advance ...

Spanish biotech SpliceBio has secured $135 million in series B financing to accelerate development of its experimental gene ...

Boston, USA-based biotech Antares Therapeutics, launched yesterday with $177 million in Series A financing. Antares is a spin ...